ArticleCancers2020
Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis.
Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.
- International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026Guideline
- Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes.Blood advances · 2025Pooled it
- A new prediction model for overall survival of elderly patients with solitary bone plasmacytoma: A population-based study.Frontiers in public health · 2022Trial
- When plasmacytoma defies expectations: An unusual maxillary presentation with mixed imaging features in a young patient.Radiology case reports · 2026Article
- Review
- Role of Radiotherapy in the Era of Novel Immune-Based Treatment Strategies for Multiple Myeloma.Hematological oncology · 2026Review
- Plasma Cell Myeloma: Biochemical Insights into Diagnosis, Treatment, and Smart Nanocarrier-Based Therapeutic Development.Pharmaceutics · 2025Review
- Article
- Population-Based Survival Analysis of Solitary Plasmacytoma of Spine in the United States From 2000 to 2020.Cancer reports (Hoboken, N.J.) · 2025Article
- Pancreatic Plasmacytoma Presenting as Acute Pancreatitis: An Unusual Extramedullary Onset of Multiple Myeloma.Cureus · 2025Article
- Clinical characteristics and prognostic factors of patients with solitary plasmacytoma: a multicenter retrospective study.Therapeutic advances in hematology · 2025Article
- Spinal Solitary Plasmacytoma With Minimal Marrow Involvement Presenting With Epidural Spinal Cord Compression.Cureus · 2024Article
- Article
- Management of Pathological Thoracolumbar Vertebral Fractures in Patients With Multiple Myeloma: Multidisciplinary Recommendations.Global spine journal · 2023Article
- Complete Resolution of Skull Base Solitary Plasmacytoma Using Proton-Beam Radiotherapy: A Case Report.Cureus · 2022Article
- Esophageal Plasmacytoma Revealed by Persistent Hiccups: A Case Report and Literature Review.Case reports in gastrointestinal medicine · 2022Article
- An Unusual Case of Multiple Myeloma with Light-Chain Cast Nephropathy Secondary to a Very Large Plasmacytoma without Bone Marrow Involvement.Case reports in hematology · 2022Article
- Surgery results in low relapse and progression rates in extramedullary plasmacytoma of the head and neck: A case cohort and review of the literature.Hematology reports · 2020Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.